Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension. - Wikidata - wikimedia - TriplyDB

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37656327

about

Treating pulmonary arterial hypertension: current treatments and future prospects Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells New perspectives for the treatment of pulmonary hypertension Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.Pulmonary vascular disease associated with schistosomiasis.Hemodynamic monitoring in pulmonary arterial hypertension.Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).An update on medical therapy for pulmonary arterial hypertension.Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.Antenatal hypoxia and pulmonary vascular function and remodeling.

P2860

Q34318473-5218B8B1-BAF3-46BA-8E5B-96949FB38C50 Q34720232-549ECC5E-ECE4-49C7-A4D7-FF116C3A0BD0 Q34903204-B863B2C9-8186-4B6A-9798-6A1CE0F8DA95 Q36795578-45572974-D4D2-44F2-8008-6010891853D1 Q37816401-39550BE3-A4F4-4527-A303-D38A684BF653 Q37867665-784DC1AC-7A3A-44C5-8DA0-C914DAA30AF4 Q38101883-C328FA3A-BD2F-46A6-B975-CCA9F8A730DB Q38152292-790C5F60-8D8D-4173-9762-86DE8FA4906C Q54476060-43AF41F0-525B-4A00-A592-85991972FC61 Q55110701-6322C525-8740-4A16-A1DE-874A118F3F62

P2860

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q37656327

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@en

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@nl

type

label

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@en

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@nl

prefLabel

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@en

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@nl

P1433

Q37656327-9154B910-0ADB-4F25-931D-9D3BCB2E4201

P1476

Q37656327-3993E983-6E13-40C2-9C3D-B900458601D2

P2093

Q37656327-179EBD8A-EAC7-4839-8E96-E486FF1F535E

Q37656327-777C6444-C164-4D10-A98F-FE13E0A14AA7

Q37656327-C92CC448-0AF4-4F7B-AAC9-27C54545AC2D

Q37656327-D4251C02-1480-42DC-AC9B-154109C21000

P2860

Q37656327-0267D736-D3FB-462E-8494-231A500018F6

Q37656327-03346185-7F94-4D4F-8692-F19042098A2D

Q37656327-03EF75D5-5490-420C-842F-292EFA4A50A1

Q37656327-040AD347-EC55-412E-8BAD-66A59C6699C3

Q37656327-04954F6F-95CC-473F-8DC6-D24CFB950F33

Q37656327-075D5891-28ED-4E5B-97AD-97176336BC5D

Q37656327-0BB4C3CA-2E78-423E-BEAC-6EB3C1ACB7E1

Q37656327-0F811F00-C983-40D4-BCAF-9A737F5D78A7

Q37656327-1053F712-DBDF-4222-BA80-0B867EE3079C

Q37656327-1119F75E-D8BA-45CB-B3FE-D8DEA9540398

P304

Q37656327-1BA28255-F54B-47BB-9319-F598DF7FC463

P31

Q37656327-AEF64B25-A94A-4893-810A-301060AFE45A

P356

Q37656327-11E4FD6E-997D-43A0-AA11-FFB7C4BA6BF6

P433

Q37656327-0A419E8F-D660-4744-8B02-0E22FD3FA5D5

P478

Q37656327-EFD3988F-14F0-4356-AA65-0CE09D94C808

P577

Q37656327-3ACC1C54-1142-43FB-B903-ADB39FE42507

P698

Q37656327-A11255A5-A92B-49C5-B4C4-3122C9A2431D

P921

Q37656327-119BDED4-B2B1-4C50-B947-09BE840C7797

P356

P1433

Future Cardiology

P1476

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

@en

P2093

Geraldine M Grant

http://www.w3.org/2001/XMLSchema#string

Mantej K Chhina

http://www.w3.org/2001/XMLSchema#string

Steven D Nathan

http://www.w3.org/2001/XMLSchema#string

Weir Nargues

http://www.w3.org/2001/XMLSchema#string

P2860

Role of endothelin-1 in lung disease

Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo

Role of platelet-derived growth factors in physiology and medicine

Clinical classification of pulmonary hypertension.

Updated clinical classification of pulmonary hypertension.

Primary pulmonary hypertension. A national prospective study.

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

P304

19-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.09.54

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20014985

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension